SPH3348 Tablets in a Single-center, Randomized, Open-label, Single-dose, Two-period, Two-sequence Crossover Design Food Effect Study in Healthy Chinese Subjects

NCT06652997 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Antitumor Drug
Pharmacokinetics

Interventions

DRUG: SPH3348

Sponsor

West China Second University Hospital

Collaborators

[object Object]